Organization
Department of Breast Surgery, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
1 abstract
Abstract
Neoadjuvant pyrotinib and inetetamab in combination with chemotherapy for locally advanced HER2-positive breast cancer (NeoPICD study): A prospective, multicenter, open-label, single-arm study.Org: Department of Thyroid and Breast Surgery, Quzhou People's Hospital, Quzhou, China, Department of Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China, Department of Breast Surgery, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China, Ruian People's Hospital, Ruian, China, Department Of Thyroid And Breast Surgery, Wenzhou Central Hospital, Wenzhou, Zhejiang, China,